GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
323.95B
LGLCX
Price
$43.38
Change
+$0.11 (+0.25%)
Updated
Jul 16 closing price
Net Assets
7.4B
Interact to see
Advertisement

GFACX vs LGLCX

Header iconGFACX vs LGLCX Comparison
Open Charts GFACX vs LGLCXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets323.95B
Lord Abbett Growth Leaders C
Price$43.38
Change+$0.11 (+0.25%)
VolumeN/A
Net Assets7.4B
GFACX vs LGLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. LGLCX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and LGLCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 324B vs. LGLCX (7.4B). GFACX (0.00) and LGLCX (0.00) have matching dividends . GFACX was incepted earlier than LGLCX: GFACX (24 years) vs LGLCX (14 years). LGLCX (1.65) is less costly to investors than GFACX (1.36). LGLCX is a more actively managed with annual turnover of: 94.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than LGLCX: GFACX (250) vs LGLCX (1500). LGLCX annual gain was more profitable for investors over the last year : 22.61 vs. GFACX (7.11). GFACX return over 5 years is better than : 35.91 vs. LGLCX (25.89).
GFACXLGLCXGFACX / LGLCX
Total Expense Ratio1.361.6582%
Annual Report Gross Expense Ratio1.361.6582%
Fund Existence24 years14 years-
Gain YTD11.2927.637148%
Front LoadN/AN/A-
Min. Initial Investment250150017%
Min. Initial Investment IRAN/AN/A-
Net Assets324B7.4B4,377%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.1122.6131%
Returns for 3 years52.0182.1963%
Returns for 5 years35.9125.89139%
Returns for 10 years63.3179.9279%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp